RankAlpha logo
Back to Rankings

IBIO

iBioA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
IBIO vs peer average
95/100
IBIO vs. peer average (A vs. D)
Grade spread
C 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CRDF is the first available peer comparator.

Loose same-sector, similar-market-cap biotech comparator. No direct operating, program, or indication match is established; use only for broad development-stage risk context.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRDFCardiff Oncology
IBIO
iBio
CRDF
Cardiff Oncology
Grade
A
C
Momentum
96
91
Value
59
41
Sentiment
69
57
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs CRDF

IBIO / CRDF
Grade Position
Above peers
IBIO vs. peer average (A vs. D)
95/100
Momentum
96
IBIO
Value
59
IBIO
Sentiment
69
IBIO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IBIO
1
CRDF
CRDF
C
60/100
+2
2
LONA
LONA
F
20/100
+4
3
RNTX
Rein Therapeutics Inc Common
F
20/100
+4
4
TELO
Telomir Pharmaceuticals Inc Common
F
20/100
+4
5
XBIT
XBiotech Inc Common
C
60/100
+2
CRDF is the first peer returned for this comparison set.